BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
SMS Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532815
ISIN Demat
INE812G01025
Book Value (Rs)
85.9335567
NSE Symbol
SMSPHARMA
Divident Yield %
0.11
Market Cap
(Rs In Cr.)
3,533
P/E (TTM)
39.02
EPS (TTM)
9.67
Face Value
(Rs)
1
Back
SMS Pharma edges higher after Q3 PAT rises nearly 29% YoY
09-Feb-26   Hrs IST

Total operating expenses for the period under review aggregated to Rs 166.80 crore, up 19.0% YoY.

PBIDT improved by 34.1% to Rs 47.40 crore in Q3 FY26 from Rs 35.34 crore in Q3 FY25.

Profit before tax in Q3 FY26 stood at Rs 31.16 crore, up by 38.9% from Rs 22.44 crore recorded in Q3 FY25.

SMS Pharmaceuticals is a diversified and integrated pharmaceutical company specializing in APIs and intermediates for global customers. The company operates two state-of-the-art manufacturing facilities in Hyderabad and Vizag.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)